Skip to main content
SpringerLink
Log in

Cardiac Manifestations of Rheumatologic Diseases

  • Chapter
  • First Online:
MGH Cardiology Board Review

  • 3148 Accesses

Abstract

Cardiac manifestations of rheumatic diseases are varied and can involve every aspect of the cardiovascular system. Although the diseases can affect any organ system the majority of patients have joint pain or constitutional symptoms as part of their presentation. The rheumatologic diseases are important to recognize as treatment of the underlying disease can alleviate its cardiovascular manifestations.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Abbreviations

ANA:

Antinuclear antibody

ANCA:

Anti-neutrophil cytoplasmic antibodies

anti-CCP:

Anti-cyclic citrullinated peptide antibody

aPL:

Antiphospholipid antibodies

AV:

Atrioventricular

bpm:

Beats per minute

CAD:

Coronary artery disease

CNS:

Central nervous system

CSS:

Churg Strauss Syndrome

CVD:

Cardiovascular disease

GI:

Gastrointestinal

HLA:

Human leukocyte antigen

ILD:

Interstitial lung disease

IVIG:

Intravenous immune globulin

MI:

Myocardial infarction

MRI:

Magnetic resonance imaging

NSAID:

Non-steroidal anti-inflammatory drug

RA:

Rheumatoid arthritis

RF:

Rheumatoid factor

SLE:

Systemic Lupus Erythematosus

TNF:

Tumor necrosis alpha

References

  1. Rostoff P, Gajos G, Konduracka E, Gackowski A, Nessler J, Piwowarska W. Lyme carditis: epidemiology, pathophysiology, and clinical features in endemic areas. Int J Cardiol. 2010;144(2):328–33.

    Article  PubMed  Google Scholar 

  2. Maradit-Kremers H, Crowson CS, Nicola PJ, et al. Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study. Arthritis Rheum. 2005;52(2):402–11.

    Article  PubMed  Google Scholar 

  3. Greenberg JD, Kremer JM, Curtis JR, et al. Tumour necrosis factor antagonist use and associated risk reduction of cardiovascular events among patients with rheumatoid arthritis. Ann Rheum Dis. 2011;70:576–82.

    Article  PubMed  Google Scholar 

  4. Esdaile JM, Abrahamowicz M, Grodzicky T, et al. Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus. Arthritis Rheum. 2001;44:2331–7.

    Article  PubMed  CAS  Google Scholar 

  5. Roman MJ, Salmon JE. Cardiovascular manifestations of rheumatologic diseases. Circulation. 2007;116(20):2346–55.

    Article  PubMed  Google Scholar 

  6. Wijetunga M, Rockson S. Myocarditis in systemic lupus erythematosus. Am J Med. 2002;113:419–23.

    Article  PubMed  Google Scholar 

  7. Nuenninghoff DM, Hunder GG, Christianson TJ, McClelland RL, Matteson EL. Incidence and predictors of large-artery complication (aortic aneurysm, aortic dissection, and/or large-artery stenosis) in patients with giant cell arteritis: a population-based study over 50 years. Arthritis Rheum. 2003;48:3522–31.

    Article  PubMed  Google Scholar 

  8. Smetana GW, Shmerling RH. Does this patient have temporal arteritis? JAMA. 2002;287:92–101.

    Article  PubMed  Google Scholar 

  9. Seferović PM, Ristić AD, Maksimović R, et al. Cardiac arrhythmias and conduction disturbances in autoimmune rheumatic diseases. Rheumatology (Oxford). 2006;45 Suppl 4:iv39–42.

    Article  Google Scholar 

  10. Meune C, Avouac J, Wahbi K, et al. Cardiac involvement in systemic sclerosis assessed by tissue-Doppler echocardiography during routine care: a controlled study of 100 consecutive patients. Arthritis Rheum. 2008;58(6):1803–9.

    Article  PubMed  Google Scholar 

  11. Reveille JD, Solomon DH. Evidence-based guidelines for the use of immunologic tests: anticentromere, Scl-70, and nucleolar antibodies. Arthritis Rheum. 2003;49(3):399–412.

    Article  PubMed  Google Scholar 

  12. Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit Care Med. 1999;160:736–55.

    Google Scholar 

  13. Newburger JW, Takahashi M, Gerber MA. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation. 2004;110(17):2747–71.

    Article  PubMed  Google Scholar 

  14. Kerr GS, Hallahan CW, Giordano J, et al. Takayasu arteritis. Ann Intern Med. 1994;120(11):919–29.

    Article  PubMed  CAS  Google Scholar 

  15. Bagnari V, Colina M, Ciancio G, Govoni M, Trotta F. Adult-onset Still’s disease. Rheumatol Int. 2010;30(7):855–62.

    Article  PubMed  CAS  Google Scholar 

  16. Neumann T, Manger B, Schmid M, et al. Cardiac involvement in Churg-Strauss syndrome: impact of endomyocarditis. Medicine (Baltimore). 2009;88(4):236–43.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Harvard Medical School Division of Rheumatology, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA

    Eli M. Miloslavsky MD (Clinical and Research Fellow)

  2. Harvard Medical School, Boston, USA

    John H. Stone MD, MPH (Professor of Medicine)

  3. Clinical Rheumatology, Division of Rheumatology, Allergy and Immunology, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA

    John H. Stone MD, MPH (Director)

Authors
  1. Eli M. Miloslavsky MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. John H. Stone MD, MPH
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. John H. Stone MD, MPH
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Cardiology Division Yawkey Building 5B, Room 5850, Massachusetts General Hospital, Boston, Massachusetts, USA

    Hanna K. Gaggin

  2. Cardiology Division Yawkey Building, Suite 5984, Massachusetts General Hospital, Boston, Massachusetts, USA

    James L. Januzzi, Jr.

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer-Verlag London

About this chapter

Cite this chapter

Miloslavsky, E.M., Stone, J.H., Stone, J.H. (2014). Cardiac Manifestations of Rheumatologic Diseases. In: Gaggin, H., Januzzi, Jr., J. (eds) MGH Cardiology Board Review. Springer, London. https://doi.org/10.1007/978-1-4471-4483-0_31

Download citation

  • DOI: https://doi.org/10.1007/978-1-4471-4483-0_31

  • Published:

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-4471-4482-3

  • Online ISBN: 978-1-4471-4483-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation